Difficulty: Medium
Average Score: 90%
Practice
A patient is receiving thrombolytic therapy, and the nurse monitors the patient for adverse effects. What is the most common undesirable effect of thrombolytic therapy?
Correct answer
C
Rationale
In the context of hematological drugs, particularly thrombolytic therapy, it is crucial for nurses to understand the potential adverse effects that may occur. The most common undesirable effect of thrombolytic therapy is internal and superficial bleeding. This occurs because thrombolytic drugs work by breaking down blood clots, which can lead to an increased risk of bleeding in various parts of the body.
Option A, dysrhythmias, is not the most common adverse effect of thrombolytic therapy. While it is possible for thrombolytic therapy to cause dysrhythmias, internal and superficial bleeding is more prevalent.
Option B, anaphylactic reactions, is less common with thrombolytic therapy compared to bleeding. Anaphylactic reactions are more commonly associated with allergic responses to medications rather than thrombolytic therapy.
Option D, nausea and vomiting, are generally not the primary adverse effects of thrombolytic therapy. While some patients may experience gastrointestinal disturbances, internal and superficial bleeding are more concerning and prevalent.
Educationally, nurses need to be able to recognize and manage the potential adverse effects of thrombolytic therapy promptly to ensure patient safety. Understanding the common undesirable effects helps nurses provide effective monitoring and interventions, ultimately improving patient outcomes.
Option A, dysrhythmias, is not the most common adverse effect of thrombolytic therapy. While it is possible for thrombolytic therapy to cause dysrhythmias, internal and superficial bleeding is more prevalent.
Option B, anaphylactic reactions, is less common with thrombolytic therapy compared to bleeding. Anaphylactic reactions are more commonly associated with allergic responses to medications rather than thrombolytic therapy.
Option D, nausea and vomiting, are generally not the primary adverse effects of thrombolytic therapy. While some patients may experience gastrointestinal disturbances, internal and superficial bleeding are more concerning and prevalent.
Educationally, nurses need to be able to recognize and manage the potential adverse effects of thrombolytic therapy promptly to ensure patient safety. Understanding the common undesirable effects helps nurses provide effective monitoring and interventions, ultimately improving patient outcomes.